0.00Open3.76Pre Close0 Volume69 Open Interest81.00Strike Price0.00Turnover51.00%IV-0.16%PremiumDec 20, 2024Expiry Date3.88Intrinsic Value100Multiplier3DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.8522Delta0.0636Gamma18.81Leverage Ratio-0.1216Theta-0.0051Rho-16.03Eff Leverage0.0166Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet